FMR CORP 13D/13G Filings for Cartesian Therapeutics, Inc. (RNAC)

FMR CORP 13D and 13G filings for Cartesian Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-12
09:28 am
Sale		 2024-12-31 13G Cartesian Therapeutics, Inc.
RNAC		 FMR CORP 2,423,213
9.400%		 -299,443decrease
(-11.00%)		 Filing
2024-08-12
09:40 am
Purchase		 2024-08-09 13G Cartesian Therapeutics, Inc.
RNAC		 FMR CORP 2,722,656
12.734%		 2,024,768increase
(+290.13%)		 Filing
2024-05-10
10:03 am
Purchase		 2024-05-09 13G Cartesian Therapeutics, Inc.
RNAC		 FMR CORP 697,888
3.925%		 697,888increase
(New Position)		 Filing